ARCHIVES

Decision To Stop NSABP P-4 Study Before It Starts Shocks Clinical Trialists.

This article is from The Cancer Letter archive.

Vol. 33 No. 08 | March 2, 2007

Download PDF Visit The Full Archive

Related Articles

With a “B” from USPSTF, Low-Dose CT Screening For Lung Cancer Earns Coverage Under ACA

August 2, 2013

NCI advisors approve recompetition of $62 million phase II contracts program.

November 19, 2004

Hope for FDA authority over tobacco products dies in Congress.

October 15, 2004

Expert Review Of ImClone Protocol Concludes C225 Approval Unlikely.

February 15, 2002

In Brief: Pasche Named Director of Wake Forest Cancer Center

March 7, 2014

Pill Associated With Cancer In BRCA1 Mutation Carriers

January 31, 2003